We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Nice
NICE
$5.97B
| $535K | ﹤0.01% |
2,680
+32
| +1% | +$5.76K |
|
2552
InterContinental Hotels
IHG
$23.2B
| $533K | ﹤0.01% |
5,846
-37
| -0.6% | -$2.92K |
|
2553
Oric Pharmaceuticals
ORIC
$1.4B
| $533K | ﹤0.01% |
57,904
-677
| -1% | -$4.89K |
|
|
AKZOY
2554
DELISTED
Akzo Nobel NV
AKZOY
| $530K | ﹤0.01% |
19,104
-110
| -0.6% | -$3.05K |
|
|
RPC
2555
Ridgepost Capital
RPC
$991M
| $529K | ﹤0.01% |
51,729
-909
| -2% | -$8.98K |
|
2556
West Bancorporation
WTBA
$485M
| $527K | ﹤0.01% |
24,836
+128
| +0.5% | +$2.29K |
|
2557
Lyell Immunopharma
LYEL
$360M
| $526K | ﹤0.01% |
13,544
+103
| +0.8% | +$3.71K |
|
2558
Fate Therapeutics
FATE
$326M
| $525K | ﹤0.01% |
140,335
-7
| -0% | -$17 |
|
2559
Zumiez
ZUMZ
$339M
| $523K | ﹤0.01% |
25,708
+51
| +0.2% | +$914 |
|
2560
Aegon
AEG
$14.1B
| $522K | ﹤0.01% |
90,691
+2,259
| +3% | +$11.7K |
|
2561
Bank of Marin Bancorp
BMRC
$459M
| $522K | ﹤0.01% |
23,716
-492
| -2% | -$9.44K |
|
2562
Esquire Financial Holdings
ESQ
$1.14B
| $522K | ﹤0.01% |
10,447
+1
| +0% | +$47 |
|
2563
MasterCraft Boat Holdings
MCFT
$590M
| $522K | ﹤0.01% |
23,053
-133
| -0.6% | -$2.86K |
|
2564
UroGen Pharma
URGN
$2.29B
| $521K | ﹤0.01% |
34,706
+7,842
| +29% | +$102K |
|
2565
Greif Class B
GEF.B
$4.21B
| $518K | ﹤0.01% |
7,841
+88
| +1% | +$5.82K |
|
|
SMMF
2566
DELISTED
Summit Financial Group, Inc.
SMMF
| $517K | ﹤0.01% |
16,856
-99
| -0.6% | -$2.39K |
|
2567
Peoples Financial Services
PFIS
$707M
| $517K | ﹤0.01% |
10,614
-27
| -0.3% | -$1.16K |
|
2568
Enliven Therapeutics
ELVN
$4.43B
| $517K | ﹤0.01% |
37,343
+2,980
| +9% | +$36.5K |
|
2569
Greenlight Captial
GLRE
$506M
| $516K | ﹤0.01% |
45,174
-243
| -0.5% | -$2.7K |
|
2570
Atmus Filtration Technologies
ATMU
$4.18B
| $514K | ﹤0.01% |
21,864
+78
| +0.4% | +$1.67K |
|
|
HLVX
2571
DELISTED
HilleVax
HLVX
| $509K | ﹤0.01% |
31,733
+4,319
| +16% | +$57.4K |
|
|
TDAY
2572
USA Today Co
TDAY
$1.06B
| $509K | ﹤0.01% |
221,367
-33,253
| -13% | -$74.1K |
|
2573
Citizens & Northern Corp
CZNC
$455M
| $509K | ﹤0.01% |
22,678
-191
| -0.8% | -$3.77K |
|
2574
Ocular Therapeutix
OCUL
$2.02B
| $508K | ﹤0.01% |
113,965
-16,051
| -12% | -$47.5K |
|
2575
South Plains Financial
SPFI
$841M
| $507K | ﹤0.01% |
17,493
-67
| -0.4% | -$1.82K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.